BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 16483675)

  • 1. Involvement of the endocannabinoid system in drug addiction.
    Maldonado R; Valverde O; Berrendero F
    Trends Neurosci; 2006 Apr; 29(4):225-32. PubMed ID: 16483675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug addiction.
    Justinova Z; Panlilio LV; Goldberg SR
    Curr Top Behav Neurosci; 2009; 1():309-46. PubMed ID: 21104390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An endocannabinoid hypothesis of drug reward and drug addiction.
    Onaivi ES
    Ann N Y Acad Sci; 2008 Oct; 1139():412-21. PubMed ID: 18991888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction.
    Lupica CR; Riegel AC
    Neuropharmacology; 2005 Jun; 48(8):1105-16. PubMed ID: 15878779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An endocannabinoid mechanism in relapse to drug seeking: a review of animal studies and clinical perspectives.
    Fattore L; Spano MS; Deiana S; Melis V; Cossu G; Fadda P; Fratta W
    Brain Res Rev; 2007 Jan; 53(1):1-16. PubMed ID: 16839608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence.
    Le Foll B; Goldberg SR
    J Pharmacol Exp Ther; 2005 Mar; 312(3):875-83. PubMed ID: 15525797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoid regulation of relapse mechanisms.
    Fattore L; Fadda P; Fratta W
    Pharmacol Res; 2007 Nov; 56(5):418-27. PubMed ID: 17936008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum.
    Oleson EB; Beckert MV; Morra JT; Lansink CS; Cachope R; Abdullah RA; Loriaux AL; Schetters D; Pattij T; Roitman MF; Lichtman AH; Cheer JF
    Neuron; 2012 Jan; 73(2):360-73. PubMed ID: 22284189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CB1 receptors in psychostimulant addiction.
    Wiskerke J; Pattij T; Schoffelmeer AN; De Vries TJ
    Addict Biol; 2008 Jun; 13(2):225-38. PubMed ID: 18482432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoid system involvement in brain reward processes related to drug abuse.
    Solinas M; Yasar S; Goldberg SR
    Pharmacol Res; 2007 Nov; 56(5):393-405. PubMed ID: 17936009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the endocannabinoid system by using CB1 cannabinoid receptor knockout mice.
    Valverde O; Karsak M; Zimmer A
    Handb Exp Pharmacol; 2005; (168):117-45. PubMed ID: 16596773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of endogenous cannabinoids from ventral tegmental area dopamine neurons and the modulation of synaptic processes.
    Wang H; Lupica CR
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jul; 52():24-7. PubMed ID: 24495779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid CB1 receptors control conditioned drug seeking.
    De Vries TJ; Schoffelmeer AN
    Trends Pharmacol Sci; 2005 Aug; 26(8):420-6. PubMed ID: 15992935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoid signaling system and brain reward: emphasis on dopamine.
    Gardner EL
    Pharmacol Biochem Behav; 2005 Jun; 81(2):263-84. PubMed ID: 15936806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoid system and drug addiction: new insights from mutant mice approaches.
    Maldonado R; Robledo P; Berrendero F
    Curr Opin Neurobiol; 2013 Aug; 23(4):480-6. PubMed ID: 23490550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential endocannabinoid regulation of extinction in appetitive and aversive Barnes maze tasks.
    Harloe JP; Thorpe AJ; Lichtman AH
    Learn Mem; 2008 Nov; 15(11):806-9. PubMed ID: 18957525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.
    Vemuri VK; Janero DR; Makriyannis A
    Physiol Behav; 2008 Mar; 93(4-5):671-86. PubMed ID: 18155257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocannabinoid-mediated synaptic plasticity and addiction-related behavior.
    Sidhpura N; Parsons LH
    Neuropharmacology; 2011 Dec; 61(7):1070-87. PubMed ID: 21669214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoid system and opioid addiction: behavioural aspects.
    Fattore L; Deiana S; Spano SM; Cossu G; Fadda P; Scherma M; Fratta W
    Pharmacol Biochem Behav; 2005 Jun; 81(2):343-59. PubMed ID: 15935459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of endocannabinoid transmission in cocaine addiction.
    Arnold JC
    Pharmacol Biochem Behav; 2005 Jun; 81(2):396-406. PubMed ID: 15925401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.